IP Watchdog

OCTOBER 20, 2022

The People’s Vaccine Alliance, a coalition of over 100 organizations, issued a statement this week alleging that the pharmaceutical industry is attempting to tighten its control of the world’s pandemic response plans.

Pharmaceuticals

Complex Discovery

NOVEMBER 3, 2024

The podcast provides an automated yet insightful look at AI’s evolving impact, enriching the way information is consumed and discussed within the legal technology field. Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy.

Government and Public Sector

Next Generation E-Discovery Law & Tech Blog

AUGUST 27, 2024

This poses major information governance challenges, as companies must decide how to manage litigation holds and retain essential data assets. Leveraging X1’s unique and patented in-place indexing technology, data extraction becomes highly targeted, allowing for efficient responses to litigation holds.

Litigation

CaseFox

NOVEMBER 27, 2023

Over time, legal frameworks developed to address these concerns, forming the foundation for contemporary exposure litigation. High-profile incidents, such as Love Canal and asbestos-related diseases, prompted regulatory changes and a surge in environmental and occupational health litigation.

Litigation

IP Watchdog

MAY 10, 2023

Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday that reversed a Patent Trial and Appeal Board (PTAB) decision invalidating claims of Sanofi’s U.S.

Pharmaceuticals

Complex Discovery

APRIL 18, 2025

Editor’s Note: Blockchain is no longer a niche technology tied solely to cryptocurrencyit is now a cornerstone of innovation across industries critical to cybersecurity, information governance, and eDiscovery. Healthcare is another field where blockchain is making significant inroads.

Government and Public Sector

IP Watchdog

AUGUST 12, 2024

Teva Pharmaceuticals (2019), the Federal Circuit rejected Celanese’s contentions that statutory changes wrought by the America Invents Act (AIA) altered the on-sale bar such that sales of products manufactured by an undisclosed process would not invalidate patents claiming that process. Following the U.S.

Pharmaceuticals

IP Watchdog

AUGUST 26, 2021

The patent generally covers cancer immunotherapy technology. The case relates to U.S. 7,446,190, owned by Sloan Kettering, which is titled “Nucleic Acids Encoding Chimeric T Cell Receptors.” Juno sued Kite Pharma, Inc. for infringement of the ‘190 patent through the sale of its YESCARTA product.

Trial Brief

Complex Discovery

MARCH 12, 2025

The deal volume reflects not only a strong appetite for growth but also the pressure businesses face to adapt to evolving technologies, regulatory landscapes, and competitive pressures. Poor governance can also lead to litigation risks if sensitive data is mismanaged. For eDiscovery professionals, the challenges are multifaceted.

Technology

The Cloud Court Blog

OCTOBER 26, 2022

Another example: As a GC managing litigation at public and private companies, I often didn’t have the time to attend or read transcripts of the depositions taken or defended by outside counsel. That’s why our tag line is: Litigate Like You Mean It. We’ll be happy to give you a sneak peek at our technology. And testimony.

Depositions

IP Watchdog

APRIL 18, 2023

The Council for Innovation Promotion (C4IP) on Monday held a webinar featuring some big names in the IP world to clear up what the organization characterizes as misguided views on the use of Title 28 of the U.S. Code, Section 1498(a). The event was prompted in part by a recent U.S. s COVID-19 vaccine.

Manufacturing

IP Watchdog

MAY 20, 2025

In a previous article, we analyzed the contours of the common law experimental use exemption. Now, we will explore the application of the exemption to common research activities, including those at universities and research institutions, in cases spanning recent decades.

Objections

IP Watchdog

JULY 1, 2024

Chamber of Commerce today responded to a recent U.S. Patent and Trademark Office (USPTO) report that the Chamber says proves much of the data that is often cited as proof of life sciences companies abusing the patent system is “more fiction than truth.”

Pharmaceuticals

Complex Discovery

JUNE 17, 2024

states over talcum powder litigation marks a pivotal moment in consumer protection and corporate accountability. This case highlights critical issues surrounding product safety, transparency, and the ethical responsibilities of corporations, especially within the pharmaceutical industry. for Mass., $6m 6m for N.H., nearly $7m for R.I.

Litigation

3 Geeks and a Law Blog

JANUARY 25, 2023

Additionally, Patent Agents can look for trends in what patents a competitor has let die before their statutory term, and what countries they are now filing in where they maybe hadn’t before with that particular technology. So that’s one example of an outside technology are company coming into png through corporate new ventures.

Technology

Securities Docket

JUNE 2, 2025

Cucinella, head of litigation and regulatory inquiries at the business headed by Republican megadonor Ken Griffin, made no mention of politics. Among them are technology giant Oracle, investment bank Morgan Stanley, an airline and a pharmaceutical company.

Pharmaceuticals